Matrix Gla Protein (MGP) (Middle Region) Peptide
MGP
Reactivité: Humain
Hôte: Synthetic
BP, IHC, WB
N° du produit ABIN980069
Aperçu rapide pour Matrix Gla Protein (MGP) (Middle Region) Peptide (ABIN980069)
Antigène
MGP
(Matrix Gla Protein (MGP))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-MGP antibody (Catalog #: ARP51308_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
Matrix Gla Protein (MGP) (AA 20-96) peptide (His tag)
MGP Reactivité: Humain Hôte: Escherichia coli (E. coli) SDS
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MGP (Matrix Gla Protein (MGP))
-
Sujet
-
MGP is associates with the organic matrix of bone and cartilage. MGP is thought to act as an inhibitor of bone formation.
Alias Symbols: GIG36, MGLAP, NTI
Protein Interaction Partner: BMP2,BMP2
Protein Size: 103 -
Poids moléculaire
- 12 kDa
-
ID gène
- 4256
-
NCBI Accession
- NM_000900, NP_000891
-
UniProt
- P08493
Antigène
-
Vous êtes ici:
